{"data":{"id":"us-dc/d.c.-code-44-109.07","jurisdiction":"us-dc","citation":"D.C. Code § 44-109.07","heading":"Medication control.","body":"(a)\nEach resident shall be identified prior to drug administration.\n\n(b)\nDrugs prescribed for one resident shall not be administered to another resident.\n\n(c)\nStaff shall report drug errors and adverse drug reactions immediately to the ALA or ALA designee who shall report, as appropriate, to the doctor, prescriber, pharmacist, resident, and resident’s surrogate and shall document the incident in the resident’s record.\n\n(d)\nA unit drug compliance package (blister or bubble or unit dose package) shall be developed and implemented where feasible.\n\n(e)\nMedications shall be refrigerated separately from lab specimens and food.","path":["Title 44. Charitable and Curative Institutions.","Chapter 1. Assisted Living Residence Regulation.","Subchapter IX. Medication Management."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/44-109.07","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"577aa388ce3a4f6e65fa7dac198af9949f0b3581ae7b9cee6d3c8962a62a0eda","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-44-109.06","next":"us-dc/d.c.-code-44-110.01"},"notice":"GroundRules: Original legal text. Not legal advice."}